Actively Recruiting
VGAIT for Chemotherapy-induced Peripheral Neuropathy
Led by Massachusetts General Hospital · Updated on 2026-02-10
20
Participants Needed
1
Research Sites
51 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Perform a feasibility study on imagined acupuncture treatment of Chemotherapy-induced peripheral neuropathy (CIPN)
CONDITIONS
Official Title
VGAIT for Chemotherapy-induced Peripheral Neuropathy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- At least 18 years of age
- Histologically confirmed stage I-III breast cancer
- Completed adjuvant taxane-based chemotherapy (alone or in combination)
- Eastern Cooperative Oncology Group performance status of 0 or 1
- Reported grade 1 or greater CIPN symptoms for more than 2 weeks as defined by NCI CTCAE version 4.03
You will not qualify if you...
- Receiving concurrent chemotherapy
- Having metastatic or recurrent disease
- History of preexisting peripheral neuropathy before chemotherapy
- Uncontrolled seizure disorder
- Unstable cardiac disease or myocardial infarction within 6 months prior to study entry
- Being pregnant or nursing
- Used acupuncture for CIPN within 6 months prior to study entry
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Massachusetts General Hospital
Charlestown, Massachusetts, United States, 02129
Actively Recruiting
Research Team
S
Sierra Hodges
CONTACT
J
Jian Kong
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here